Health claim deadlines
This article was originally published in The Tan Sheet
Executive Summary
FDA has extended the deadline for response to Nutrition 21's citizen petition for qualified health claims linking chromium picolinate to Type 2 diabetes to Aug. 16, the firm announces June 21. The extension is the fourth since the the petition was submitted in December 2003 (1"The Tan Sheet," Jan. 12, 2004, p. 15). Deadlines also have been extended by FDA for review of a health claim petition submitted by Marine Bio linking calcium to conditions such as cancer and menstrual pain, and a petition for green tea claims for cancer submitted by Fleminger...
You may also be interested in...
Chromium Picolinate Diabetes Claims Sought By Nutrition 21
Nutrition 21 is requesting FDA approval of eight dietary supplement health claims linking use of chromium picolinate to reduced risk of insulin resistance, type 2 diabetes and related health problems, the company announced January 7
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.